The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. 2021

Alexandra Daks, and Alexey Petukhov, and Olga Fedorova, and Oleg Shuvalov, and Alena Kizenko, and Elizaveta Tananykina, and Elena Vasileva, and Oleg Semenov, and Andrew Bottrill, and Nickolai Barlev
Institute of Cytology, Russian Academy of Sciences, 194064, St Petersburg, Russian Federation. alexandra.daks@gmail.com.

The RING-finger protein Pirh2 is a p53 family-specific E3 ubiquitin ligase. Pirh2 also ubiquitinates several other important cellular factors and is involved in carcinogenesis. However, its functional role in other cellular processes is poorly understood. To address this question, we performed a proteomic search for novel interacting partners of Pirh2. Using the GST-pulldown approach combined with LC-MS/MS, we revealed 225 proteins that interacted with Pirh2. We found that, according to the GO description, a large group of Pirh2-associated proteins belonged to the RNA metabolism group. Importantly, one of the identified proteins from that group was an RNA-binding protein ELAVL1 (HuR), which is involved in the regulation of splicing and protein stability of several oncogenic proteins. We demonstrated that Pirh2 ubiquitinated the HuR protein facilitating its proteasome-mediated degradation in cells. Importantly, the Pirh2-mediated degradation of HuR occurred in response to heat shock, thereby affecting the survival rate of HeLa cells under elevated temperature. Functionally, Pirh2-mediated degradation of HuR augmented the level of c-Myc expression, whose RNA level is otherwise attenuated by HuR. Taken together, our data indicate that HuR is a new target of Pirh2 and this functional interaction contributes to the heat-shock response of cancer cells affecting their survival.

UI MeSH Term Description Entries
D009857 Oncogenes Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene. Transforming Genes,Oncogene,Transforming Gene,Gene, Transforming,Genes, Transforming
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067780 ELAV-Like Protein 1 An RRM protein that binds to the 3'-UTR region of mRNAs and increases their stability. In EMBRYONIC STEM CELLS, it binds to poly-U elements and AU-rich elements (AREs) in the 3'-UTR of target mRNAs and preferentially binds mRNAs that are not methylated by N6-methyladenosine (m6A), to stabilize them and promote differentiation. ELAVL1 protein,HuR Antigen,HuR Paraneoplastic Encephalomyelitis Antigen,HuR Protein,Antigen, HuR,ELAV Like Protein 1,Protein, HuR,protein, ELAVL1
D016601 RNA-Binding Proteins Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA. Double-Stranded RNA-Binding Protein,Double-Stranded RNA-Binding Proteins,ds RNA-Binding Protein,RNA-Binding Protein,ds RNA-Binding Proteins,Double Stranded RNA Binding Protein,Double Stranded RNA Binding Proteins,Protein, Double-Stranded RNA-Binding,Protein, ds RNA-Binding,RNA Binding Protein,RNA Binding Proteins,RNA-Binding Protein, Double-Stranded,RNA-Binding Protein, ds,RNA-Binding Proteins, Double-Stranded,ds RNA Binding Protein
D044767 Ubiquitin-Protein Ligases A diverse class of enzymes that interact with UBIQUITIN-CONJUGATING ENZYMES and ubiquitination-specific protein substrates. Each member of this enzyme group has its own distinct specificity for a substrate and ubiquitin-conjugating enzyme. Ubiquitin-protein ligases exist as both monomeric proteins multiprotein complexes. Ubiquitin-Protein Ligase,E3 Ligase,E3 Ubiquitin Ligase,Ubiquitin Ligase E3,Ubiquitin-Protein Ligase E3,Ligase E3, Ubiquitin,Ligase E3, Ubiquitin-Protein,Ligase, E3,Ligase, E3 Ubiquitin,Ligase, Ubiquitin-Protein,Ligases, Ubiquitin-Protein,Ubiquitin Ligase, E3,Ubiquitin Protein Ligase,Ubiquitin Protein Ligase E3,Ubiquitin Protein Ligases
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D057809 HEK293 Cells A cell line generated from human embryonic kidney cells that were transformed with human adenovirus type 5. 293T Cells,HEK 293 Cell Line,HEK 293 Cells,Human Embryonic Kidney Cell Line 293,Human Kidney Cell Line 293,293 Cell, HEK,293 Cells, HEK,293T Cell,Cell, 293T,Cell, HEK 293,Cell, HEK293,Cells, 293T,Cells, HEK 293,Cells, HEK293,HEK 293 Cell,HEK293 Cell

Related Publications

Alexandra Daks, and Alexey Petukhov, and Olga Fedorova, and Oleg Shuvalov, and Alena Kizenko, and Elizaveta Tananykina, and Elena Vasileva, and Oleg Semenov, and Andrew Bottrill, and Nickolai Barlev
May 2021, International journal of molecular sciences,
Alexandra Daks, and Alexey Petukhov, and Olga Fedorova, and Oleg Shuvalov, and Alena Kizenko, and Elizaveta Tananykina, and Elena Vasileva, and Oleg Semenov, and Andrew Bottrill, and Nickolai Barlev
May 2013, The Journal of investigative dermatology,
Alexandra Daks, and Alexey Petukhov, and Olga Fedorova, and Oleg Shuvalov, and Alena Kizenko, and Elizaveta Tananykina, and Elena Vasileva, and Oleg Semenov, and Andrew Bottrill, and Nickolai Barlev
December 2007, Biochemical and biophysical research communications,
Alexandra Daks, and Alexey Petukhov, and Olga Fedorova, and Oleg Shuvalov, and Alena Kizenko, and Elizaveta Tananykina, and Elena Vasileva, and Oleg Semenov, and Andrew Bottrill, and Nickolai Barlev
December 2011, Molecular cancer research : MCR,
Alexandra Daks, and Alexey Petukhov, and Olga Fedorova, and Oleg Shuvalov, and Alena Kizenko, and Elizaveta Tananykina, and Elena Vasileva, and Oleg Semenov, and Andrew Bottrill, and Nickolai Barlev
February 2010, Molecular and cellular biology,
Alexandra Daks, and Alexey Petukhov, and Olga Fedorova, and Oleg Shuvalov, and Alena Kizenko, and Elizaveta Tananykina, and Elena Vasileva, and Oleg Semenov, and Andrew Bottrill, and Nickolai Barlev
February 2003, Journal of cell science,
Alexandra Daks, and Alexey Petukhov, and Olga Fedorova, and Oleg Shuvalov, and Alena Kizenko, and Elizaveta Tananykina, and Elena Vasileva, and Oleg Semenov, and Andrew Bottrill, and Nickolai Barlev
March 2002, The Journal of biological chemistry,
Alexandra Daks, and Alexey Petukhov, and Olga Fedorova, and Oleg Shuvalov, and Alena Kizenko, and Elizaveta Tananykina, and Elena Vasileva, and Oleg Semenov, and Andrew Bottrill, and Nickolai Barlev
September 2010, Asian journal of andrology,
Alexandra Daks, and Alexey Petukhov, and Olga Fedorova, and Oleg Shuvalov, and Alena Kizenko, and Elizaveta Tananykina, and Elena Vasileva, and Oleg Semenov, and Andrew Bottrill, and Nickolai Barlev
June 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Alexandra Daks, and Alexey Petukhov, and Olga Fedorova, and Oleg Shuvalov, and Alena Kizenko, and Elizaveta Tananykina, and Elena Vasileva, and Oleg Semenov, and Andrew Bottrill, and Nickolai Barlev
January 2018, The Journal of biological chemistry,
Copied contents to your clipboard!